Securities fraud litigation history and active cases
In Litigation
0
Settlement
0
Closed
1
Total Settlement
$0
1:19cv11282 • June 10, 2019
Class Period Start
March 8, 2017
Class Period End
February 13, 2018
PSLRA Deadline
September 25, 2018
Case Allegations
10b5 + Sec11
10b-5 Statutes of Repose
Mar 8, 2020
Sec11 Statutes of Repose
Jul 27, 2020
Country
United States
Court
Federal Court
Oct 1, 2019
Voluntary Dismissal
The plaintiff in this action has chosen not to proceed with the case. Once a case is voluntary dismissed, the courts will usually close the case and no further action will be taken.
Aug 2, 2019
Appointment of Lead Plaintiff
The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.
Jul 27, 2018
First Filed Complaint
A securities fraud class action complaint has been filed on behalf of certain investors in TETRAPHASE PHARMACEUTICALS INC.
TOP
